2026– date –
-
Translational Progress in Lipid Nanoparticle Drug Delivery Systems for Cancer Therapy: Current Status and Future Horizons
PMC (PubMed Central) International Overview This review article comprehensively examines lipid nanoparticles (LNPs) as highly adaptable nanocarrier systems for cancer therapy and diagnostics. LNPs leverage structural flexibility, biocomp... -
Boosting Lithium-Ion Anodes: Carbon Nanotubes Forge Superior Conductive Networks
POLITesi (Politecnico di Torino) イタリア Overview Researchers at Politecnico di Torino have demonstrated that incorporating carbon nanotubes (CNTs) as conductive additives significantly enhances the electrochemical performance of lithiu... -
OCSiAl Launches Advanced SWCNTs for High-Performance Electrodes and Next-Gen Battery Systems
OCSiAl ルクセンブルク Overview OCSiAl, a global leader in single-walled carbon nanotube (SWCNT) technology, has unveiled a new suite of SWCNT products optimized for high-performance battery electrodes and emerging chemistries. These inno... -
Fujikura and MIT Introduce ‘Implosion Carving’: A New Paradigm for 3D Nanofabrication
株式会社フジクラのプレスリリース Japan Overview Fujikura, in collaboration with MIT, has unveiled "Implosion Carving (ImpCarv)," a groundbreaking 3D nanofabrication technique published in Nature Photonics. This method precisely sculpts i... -
Samsung Unveils Next-Gen Odyssey Gaming Monitors with Penta Tandem QD-OLED, Including Industry-First 6K Model
Samsung South Korea Overview Samsung has launched an advanced lineup of Odyssey gaming monitors, highlighted by the new 27-inch and 32-inch Odyssey OLED G8 (G80SH) models, featuring 4K resolution and 240Hz refresh rates. These displays i... -
Samsung Display Elevates QD-OLED Performance with Penta Tandem Technology: Achieving 320Hz, 1300 Nits, and Doubled Lifespan
FlatpanelsHD デンマーク Overview Samsung Display has integrated its advanced Penta Tandem technology into its 27-inch 1440p QD-OLED panels, delivering a significant leap in display performance. This enhancement boosts refresh rates to 32... -
Vertex Pharmaceuticals Secures CASGEVY Reimbursement Agreement in Germany for Sickle Cell Disease and Beta Thalassemia
Vertex Pharmaceuticals USA Overview Vertex Pharmaceuticals announced a reimbursement agreement in Germany for CASGEVY (exa-cel), a groundbreaking gene-editing therapy for sickle cell disease (SCD) and transfusion-dependent beta thalassem... -
iPSC-Derived Retinal Sheet Transplantation for Retinitis Pigmentosa: Clinical Trial Validates Long-Term Safety and Engraftment
臨床研究等提出・公開システム (jRCT) Japan Overview A pioneering clinical study (jRCTa050200027) conducted by Kobe City Eye Center Hospital has concluded, affirming the long-term safety and engraftment of allogeneic iPSC-derived retinal s... -
SelectBIO to Host Lipid Nanoparticles (LNPs) Asia/Pacific 2026: Driving mRNA Delivery Innovations
SelectBIO Conferences UK Overview SelectBIO Conferences will host the 'Lipid Nanoparticles (LNPs) Asia/Pacific 2026' event, focusing on LNPs, extracellular vesicles, exosomes, and Japanese research. The conference will primarily address ... -
The Future of Healing: Gene Therapy in 2026 Navigates CRISPR Advances and Access Challenges
薬事日報 Japan Overview By 2026, gene therapy is undergoing a paradigm shift, moving towards direct repair or replacement of disease-causing genes. CRISPR-based in vivo editing shows early clinical promise, pushing the vision of single-i...
